It?s been 34 years since the first case of AIDS was identified, and 28 years since the first treatment for AIDS was approved by the FDA. In the past three decades, we?ve made advances in treatments for HIV/AIDS but a cure has remained elusive. Now an innovative public-private partnership between GSK and the University of North Carolina at Chapel Hill (UNC-Chapel Hill) aims to change that by establishing an HIV Cure center and a new jointly-owned company, Qura Therapeutics.
The center will be located on the UNC-Chapel Hill campus and will focus exclusively on finding a cure for HIV/AIDS. Qura Therapeutics will handle the business side of the partnership, including intellectual property, commercialization, manufacturing and governance.
Read the release: http://bit.ly/1AXCzYh
? 2015 | 3BL Media/GSK | All Rights Reserved
